Provided by Tiger Trade Technology Pte. Ltd.

Novavax

9.26
+0.21002.32%
Post-market: 9.280.0200+0.22%19:59 EDT
Volume:4.21M
Turnover:38.42M
Market Cap:1.52B
PE:-6.10
High:9.34
Open:9.18
Low:8.89
Close:9.05
52wk High:11.97
52wk Low:6.20
Shares:164.43M
Float Shares:143.00M
Volume Ratio:0.70
T/O Rate:2.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5181
EPS(LYR):2.58
ROE:-898.20%
ROA:-6.51%
PB:-7.98
PE(LYR):3.59

Loading ...

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 19

Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029

Reuters
·
Jun 18

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 18

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 16

Novavax (NVAX) Stock Revalued After Pivot To Sanofi Deal And Matrix M Licensing Model

Simply Wall St.
·
Jun 13

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and Novavax (NVAX)

TIPRANKS
·
Jun 12

Novavax Price Target Maintained With a $19.00/Share by BTIG

Dow Jones
·
Jun 12

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 12

Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jun 11

Novavax Inc. Stock Sheds 9.2%, Underperforms Peers

Dow Jones
·
Jun 09

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jun 06

Novavax’s Combo COVID-19 and Flu Shot Trial Reaches Key Milestone for Older Adults

TIPRANKS
·
Jun 06

Novavax and Sanofi Advance Omicron JN.1 Booster With Completed Phase 3 Study

TIPRANKS
·
Jun 06

Novavax Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02

Novavax to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
Jun 02

Novavax Inc. Stock Rallies 6.3%, Outperforms Peers

Dow Jones
·
May 30

US FDA Advisers Vote in Favor of Recommending Covid Vaccines Target Jn.1 Lineage Xfg Variant for 2026-27 Campaign

THOMSON REUTERS
·
May 29

Stock Track | Novavax Plummets 5.04% Intraday on FDA Vaccine Composition Uncertainty

Stock Track
·
May 28

Sanofi Says Manufacturing Xfg Protein Nuvaxovid Vaccine as Its Single Global Covid-19 Product for the 2026-27 Season: Briefing Docs

THOMSON REUTERS
·
May 28

FDA advisers to weigh composition of COVID vaccines for 2026-2027

Reuters
·
May 28